Research progress on predictive factors and time points of adaptive re-planning in intensity-modulated radiation therapy for head and neck cancer
Guo Qi, Qian Jianjun, Tian Ye
Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University Institute of Radiotherapy& Oncology, Soochow University Suzhou Key Laboratory for Radiation Oncology, Suzhou 215004,China
Abstract：Adaptive re-planning contributes to improve the dosimetric uncertainties induced by anatomical changes during intensity-modulated radiation therapy (IMRT) for head and neck cancer patients and can enhance the local control rate and quality of life of patients. Previous research has demonstrated that presence of relatively large lymph nodes before treatment and significant loss of body weight during treatment are pivotal predictive factors of re-planning during IMRT. At 4 weeks after IMRT, the volume of the target and peripheral organ at risk (OAR) tends to steadily decrease. One to two cycles of adaptive re-planning are recommended at 3 or 4 weeks after IMRT.
Guo Qi,Qian Jianjun,Tian Ye. Research progress on predictive factors and time points of adaptive re-planning in intensity-modulated radiation therapy for head and neck cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(2): 206-209.
[1] Barker Jr JL,Garden AS,Ang KK,et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system[J].Int J Radiat Oncol Biol Phys,2004,59(4):960-970.DOI:10.1016/j.ijrobp.2003.12.024. [2] Capelle L,Mackenzie M,Field C,et al. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings:initial results[J].Clin Oncol,2011,24(3):208-215.DOI:10.1016/j.clon.2011.11.005. [3] Han CH,Chen Y J,Liu A,et al. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy[J].Int J Radiat Oncol Biol Phys,2008,70(4):1256-1262.DOI:10.1016/j.ijrobp.2007.10.067. [4] Nishi T,Nishimura Y,Shibata T,et al. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer[J].Radiother Oncol,2013,106(1):85-89.DOI:10.1016/j.radonc.2012.11.005. [5] Salama JK,Haddad RI,Kies MS,et al. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2009,75(3):725-733.DOI:10.1016/j.ijrobp.2008.11.059. [6] Hansen EK,Bucci MK,Quivey JM,et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2006,64(2):355-362.DOI:10.1016/j.ijrobp.2005.07.957. [7] Chen AM,Daly ME,Cui J,et al. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning[J].Head Neck,2014,36(11):1541-1546.DOI:10.1002/hed.23477. [8] Lee H,Ahn YC,Oh D,et al. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer[J].Head Neck,2014,36(4):499-504.DOI:10.1002/hed.23328. [9] Schwartz DL,Garden AS,Thomas J,et al. Adaptive radiotherapy for head-and-neck cancer:initial clinical outcomes from a prospective trial[J].Int J Radiat Oncol Biol Phys,2012,83(3):986-993.DOI:10.1016/j.ijrobp.2011.08.017. [10] Zhao L,Wan QY,Zhou YQ,et al. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma[J].Radiother Oncol,2011,98(1):23-27.DOI:10.1016/j.radonc.2010.10.009. [11] Vanderstraeten B,Berwouts D,Goddeeris B,et al. Adaptive intensity-modulated radiation therapy for head and neck cancer:is it affordable?[J].Int J Radiat Oncol Biol Phys,2014,90(S1):S107-S108.DOI:10.1016/j.ijrobp.2014.05.524. [12] Bhide SA,Davies M,Burke K,et al. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer:a prospective observational study[J].Int J Radiat Oncol Biol Phys,2010,76(5):1360-1368.DOI:10.1016/j.ijrobp.2009.04.005. [13] Gabriele P,Garibaldi E,Cattari G,et al. Po-0791 adaptive radiotherapy in imrt-igrt of head and neck cancers:decisional parameters for replanning[J].Radiother Oncol,2012,103(S1):S307.DOI:10.1016/S0167-8140(12)71124-6. [14] Wang W,Yang HH,Hu W,et al. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,2010,77(2):617-621.DOI:10.1016/j.ijrobp.2009.08.036. [15] Bhandari V,Patel P,Gurjar OP,et al. Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers[J].J Appl Phys,2014,39(3):164-168.DOI:10.4103/0971-6203.139005. [16] Surucu M,Shah KK,Roeske JC,et al. Adaptive Radiotherapy for Head and Neck Cancer:implications for clinical and dosimetry outcomes[J].Technol Cancer Res Treat,2017,16(2):218-223.DOI:10.1177/1533034616662165. [17] Wu QW,Chi YW,Chen PY,et al. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT[J].Int J Radiat Oncol Biol Phys,2009,75(3):924-932.DOI:10.1016/j.ijrobp.2009.04.047. [18] Zhang X,Li M,Cao J,et al. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy[J].Br J Radiol,2012,85(1016):e506-e513.DOI:10.1259/bjr/20695672. [19] Jin XC,Hu WG,Shang HJ,et al. CBCT-based volumetric and dosimetric variation evaluation of volumetric modulated arc radiotherapy in the treatment of nasopharyngeal cancer patients[J].Radiat Oncol,2013,8(1):279.DOI:10.1186/1748-717X-8-279. [20] Lee BK,Zhang J,Cho-Lim JJ,et al. Adaptive radiation therapy for head and neck cancers:a veterans affairs single-institution experience[J].Int J Radiat Oncol Biol Phys,2016,96(S2):E339-E340.DOI:10.1016/j.ijrobp.2016.06.1480. [21] Ricchetti F,Wu BB,McNutt T,et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer[J].Int J Radiat Oncol Biol Phys,2011,80(1):161-168.DOI:10.1016/j.ijrobp.2010.01.071. [22] Guidi G,Maffei N,Meduri B,et al. A machine learning tool for re-planning and adaptive RT:a multicenter cohort investigation[J].Phys Med,2016,32(12):1659-1666.DOI:10.1016/j.ejmp.2016.10.005. [23] Fiorentino A,Caivano R,Metallo V,et al. Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer[J].Br J Radiol,2012,85(1018):1415-1419.DOI:10.1259/bjr/30678306. [24] Castelli J,Simon A,Louvel G,et al. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia[J].Radiat Oncol,2015,10(1):6.DOI:10.1186/s13014-014-0318-z. [25] Brown E,Owen R,Harden F,et al. Predicting the need for adaptive radiotherapy in head and neck cancer[J].Radiother Oncol,2015,116(1):57-63.DOI:10.1016/j.radonc.2015.06.025. [26] Ma L,Yao WR,Xu SP,et al. Replanning criteria and timing definition for parotid protection-based adaptive radiation therapy in nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,2015,90(1):S522-S523.DOI:10.1016/j.ijrobp.2014.05.1597. [27] Huang HX,Lu HM,Feng GS,et al. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy[J].Radiat Oncol,2015,10:192.DOI:10.1186/s13014-015-0498-1. [28] Yan D,Yan S,Wang Q,et al. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy:a prospective observational study[J].BMC Cancer,2013,13:548.DOI:10.1186/1471-2407-13-548. [29] Beltran M,Ramos M,Rovira JJ,et al. Dose variations in tumor volumes and organs at risk during IMRT for head-and-neck cancer[J].J Appl Clin Med Phys,2012,13(6):101-111.DOI:10.1120/jacmp.v13i6.3723. [30] Fung WWK,Wu VWC,Teo PML.Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma[J].J Radiat Res,2014,55(2):293-304.DOI:10.1093/jrr/rrt103. [31] Brown E,Owen R,Harden F,et al. Head and neck adaptive radiotherapy:predicting the time to replan[J].Asia Pac J Clin Oncol,2016,12(4):460-467.DOI:10.1111/ajco.12516. [32] Surucu M,Shah KK,Mescioglu I,et al. Decision trees predicting tumor shrinkage for head and neck cancer:implications for adaptive radiotherapy[J].Technol Cancer Res Treat,2016,15(1):139-145.DOI:10.1177/1533034615572638. [33] Fiorentino A,Cozzolino M,Caivano R,et al. Head and neck intensity modulated radiotherapy parotid glands:time of re-planning[J].La Radiol Med,2014,119(3):201-207.DOI:10.1007/s11547-013-0326-3. [34] Chitapanarux I,Chomprasert K,Nobnaop W,et al. A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer[J].J Radiat Res,2015,56(3):529-538.DOI:10.1093/jrr/rru119. [35] Olteanu LAM,Berwouts D,Madani I,et al. Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer[J].Radiother Oncol,2014,111(3):348-353.DOI:10.1016/j.radonc.2014.02.017. [36] Zhang PC,Simon A,Rigaud B,et al. Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer[J].Radiother Oncol,2016,120(1):41-47.DOI:10.1016/j.radonc.2016.05.028. [37] Luo Y,Qin Y,Lang J.Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy:a propensity score matched analysis[J].Clin Transl Oncol,2017,19(4):470-476.DOI:10.1007/s12094-016-1551-8. [38] Yang HH,Hu W,Wang W,et al. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,2013,85(1):e47-e54.DOI:10.1016/j.ijrobp.2012.09.033.
2018, Vol. 27 
